Global Nasal Drug Delivery Technology Market was valued US$ 12.04 Bn in 2019 and is expected to reach US$ XX Bn by 2026, at a CAGR of XX % during a forecast period.
The report includes the analysis of impact of COVID-19 lock-down on the revenue of market leaders, followers, and disrupters. Since lock down was implemented differently in different regions and countries, impact of same is also different by regions and segments. The report has covered the current short term and long term impact on the market, same will help decision makers to prepare the outline for short term and long term strategies for companies by region.
The nasal drug delivery technology market is majorly segmented into dosage form, container, system, therapeutic application, end user, and region.
On the basis of the container, the non-pressurized containers segment is expected to account for the XX% share of the market due to the better versatility and reliability, instant availability, self-containment, better portability, and low-cost medical aerosol delivery. In addition, the increasing use of these devices for the treatment of reversible airflow obstruction resulting from asthma and chronic obstructive pulmonary disease is expected to further drive the growth of this market during the forecast period.
In terms of end-user, hospitals are among the major end users for nasal drug delivery, the substantial growth in the number of patients suffering from chronic rhinitis is a key market driver for this end-user segment.
The major driving factor of the global nasal drug delivery technology market is increasing patient preference for nasal drug delivery as a result of easy administration and better efficacy and growing adoption of self-administration practices.
Complications associated with the overuse of nasal sprays are hindering the global nasal drug delivery technology market growth.
Regulatory hurdles are the major challenge of the global nasal drug delivery technology market.
The key players operating in the global nasal drug delivery technology market are Aegis Therapeutics LLC, Aptargroup, Inc., Astrazeneca PLC, Glaxosmithkline PLC, Johnson & Johnson Services, Inc., Merck & Co., Inc., Novartis AG, Pfizer Inc., and 3M.
The Scope of Global Nasal Drug Delivery Technology Market:
Global Nasal Drug Delivery Technology Market, by Dosage Form:
• Sprays
• Drops & Liquids
• Powders
• Gels
Global Nasal Drug Delivery Technology Market, by Container:
• Pressurized Containers
• Non-pressurized Containers
Global Nasal Drug Delivery Technology Market, by System:
• Multi-dose Systems
• Bi-dose Systems
• Unit-dose Systems
Global Nasal Drug Delivery Technology Market by Therapeutic Application:
• Allergic And Non-allergic Rhinitis
• Nose Congestion
• Vaccination
• Other Therapeutic Applications
Global Nasal Drug Delivery Technology Market by End User:
• Home Care Settings
• Hospitals
Global Nasal Drug Delivery Technology Market, by Region:
• North America
• Europe
• Middle East & Africa
• Asia Pacific
• Latin America
The key players operating in the Global Nasal Drug Delivery Technology Market:
• Aegis Therapeutics LLC
• Aptargroup, Inc.
• Astrazeneca PLC
• Glaxosmithkline PLC
• Johnson & Johnson Services, Inc.
• Merck & Co., Inc.
• Novartis AG
• Pfizer Inc.
• 3M
Global Nasal Drug Delivery Technology Market Visit Full Report Below links : https://www.maximizemarketresearch.com/market-report/global-nasal-drug-delivery-technology-market/21190/
About Us:
Maximize Market Research provides B2B and B2C market research on 20,000 high growth emerging technologies & opportunities in Chemical, Healthcare, Pharmaceuticals, Electronics & Communications, Internet of Things, Food and Beverages, Aerospace and Defense and other manufacturing sectors.
Contact info:
Name: Vikas Godage
Organization: Maximize Market Research Pvt.Ltd.Pune
Email: [email protected]
Contact: +919607065656 / +919607195908
Website:www.maximizemarketresearch.com
In 2018, the global Nasal Drug Delivery Technology market size was million US$ and it is expected to reach million US$ by the end of 2025, with a CAGR of during 2019-2025.
This report focuses on the global Nasal Drug Delivery Technology status, future forecast, growth opportunity, key market and key players.
The study objectives are to present the Nasal Drug Delivery Technology development in United States, Europe and China.Report Sample includes:- Table of Contents- List of Tables & Figures- Charts- Research MethodologyGet FREE Sample of this Report at https://www.24marketreports.com/report-sample/global-nasal-drug-delivery-technology-2019-2025-62 The key players covered in this studyMerck & Co., Inc.Novartis AGGlaxosmithkline PLCJohnson & Johnson Services, Inc.Pfizer Inc.3MBecton, Dickinson and CompanyAegis Therapeutics LLCAptargroup, Inc.AstrazenecaMarket segment by Type, the product can be split into SpraysDrops & LiquidsPowdersGelsMarket segment by Application, split into Allergic And Non-allergic RhinitisNose CongestionVaccinationOther Therapeutic ApplicationsMarket segment by Regions/Countries, this report covers United StatesEuropeChinaJapanSoutheast AsiaIndiaCentral & South AmericaThe study objectives of this report are: To analyze global Nasal Drug Delivery Technology status, future forecast, growth opportunity, key market and key players.To present the Nasal Drug Delivery Technology development in United States, Europe and China.To strategically profile the key players and comprehensively analyze their development plan and strategies.To define, describe and forecast the market by product type, market and key regions.In this study, the years considered to estimate the market size of Nasal Drug Delivery Technology are as follows: History Year: 2014-2018Base Year: 2018Estimated Year: 2019Forecast Year 2019 to 2025Get the Complete Report & TOC at https://www.24marketreports.com/life-sciences/global-nasal-drug-delivery-technology-2019-2025-62 CONTACT US:276 5th Avenue, New York , NY 10001,United StatesInternational: (+1) 646 781 7170Email: [email protected] Us On linkedin :- https://www.linkedin.com/company/24-market-reports
Nasal Drug Delivery Technology Market by Dosage Form (Nasal Drops, Sprays, Powder, Gel), System (Multidose, Unit Dose, BI-Dose), Therapeutic Applications (Rhinitis, Congestion, Vaccinations), End User (Hospitals, Homecare) – Global Forecast to 2021″ published by MarketsandMarkets™, the global nasal drug delivery technology market is projected to reach USD 64.20 Billion by 2021 from USD 44.00 Billion in 2016, at a CAGR of 6.5% during the forecast period.Don’t miss out on business opportunities in Nasal Drug Delivery Technology Market.Speak to our analyst and gain crucial industry insights that will help your business grow: https://www.marketsandmarkets.com/speaktoanalyst.asp?id=192818058Increasing patient preference for nasal drug delivery because of easy administration & better efficacy and growing adoption of self-administration practices are some of the major factors driving the growth of the nasal drug delivery technology market.
Furthermore, growth among over-the-counter nasal drugs and increasing focus on alternative routes of drug delivery such as nasal drug delivery offers significant growth opportunities for player operating in the market.
On the other hand, complications associated with the overuse of nasal sprays may restraint the growth of the market.The nasal drug delivery technology market is segmented based on dosage form, therapeutic application, end user, system, container, and region.
Based on therapeutic application, the market is segmented into allergic and non-allergic rhinitis, nasal congestion, vaccination, and other therapeutic applications (osteoporosis, pain management, and sexual dysfunction).
The high growth in this segment can primarily be attributed to the increasing prevalence of allergic and non-allergic rhinitis and growing preference for nasal drugs for its treatment.Browse and in-depth TOC on “Nasal Drug Delivery Technology Market ”95 – Tables36 – Figures212 – PagesView more detailed TOC @ https://www.marketsandmarkets.com/Market-Reports/nasal-drug-delivery-technology-market-192818058.htmlBased on region, the nasal drug delivery technology market is segmented into North America, Europe, Asia, and the Rest of the World (RoW).
North America is further subsegmented into the U.S. and Canada; while Europe is further subsegmented into Germany, France, the U.K., and Rest of Europe (RoE); Asia is further subsegmented into Japan, China, India, and Rest of Asia (RoA).
